Essential medicines for universal health coverage

VJ Wirtz, HV Hogerzeil, AL Gray, M Bigdeli… - The Lancet, 2017‏ - thelancet.com
Executive summary Essential medicines satisfy the priority health-care needs of the
population. Essential medicines policies are crucial to promoting health and achieving …

Barriers for conducting clinical trials in develo** countries-a systematic review

C Alemayehu, G Mitchell, J Nikles - International journal for equity in …, 2018‏ - Springer
Background Clinical trials for identification of efficient and effective new diagnostic and
treatment modalities are needed to address disproportionately high burden of …

Governance challenges in global health

J Frenk, S Moon - New England Journal of Medicine, 2013‏ - Mass Medical Soc
Governance Challenges in Global Health | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Map** of available health research and development data: what's there, what's missing, and what role is there for a global observatory?

JA Røttingen, S Regmi, M Eide, AJ Young… - The Lancet, 2013‏ - thelancet.com
The need to align investments in health research and development (R&D) with public health
demands is one of the most pressing global public health challenges. We aim to provide a …

Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment

TK Mackey, BA Liang, R Cuomo, R Hafen… - Clinical microbiology …, 2014‏ - journals.asm.org
In global health, critical challenges have arisen from infectious diseases, including the
emergence and reemergence of old and new infectious diseases. Emergence and …

How can pricing and reimbursement policies improve affordable access to medicines? Lessons learned from European countries

S Vogler, V Paris, A Ferrario, VJ Wirtz… - … health economics and …, 2017‏ - Springer
This article discusses pharmaceutical pricing and reimbursement policies in European
countries with regard to their ability to ensure affordable access to medicines. A frequently …

Innovation in neglected tropical disease drug discovery and development

HB Weng, HX Chen, MW Wang - Infectious diseases of poverty, 2018‏ - mednexus.org
Background: Neglected tropical diseases (NTDs) are closely related to poverty and affect
over a billion people in develo** countries. The unmet treatment needs cause high …

Market failures and market framings: Can a market be transformed from the inside?

S Geiger, N Gross - Organization Studies, 2018‏ - journals.sagepub.com
How do actors innovate markets in cases of perceived market failures? This paper's aim is to
examine what happens when a market is innovated or, as we call it,'redevised'in situations …

Who sets the global health research agenda? The challenge of multi-bi financing

D Sridhar - 2012‏ - journals.plos.org
As part of a cluster of articles critically reflecting on the theme of “no health without research,”
Devi Sridhar discusses a major challenge in the governance of research funding:“multi-bi” …

The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and …

RF Viergever - Global Health Action, 2013‏ - Taylor & Francis
One of the most pressing global health problems is that there is a mismatch between the
health research and development (R&D) that is needed and that which is undertaken. The …